DaShenLin Pharmaceutical Group Co., Ltd.
603233
Clasificación en acciones
#4892
Established in 1999, DaShenLin Pharmaceutical Group Co., Ltd. is a Chinese... Established in 1999, DaShenLin Pharmaceutical Group Co., Ltd. is a Chinese company based in Guangzhou. It operates across the pharmaceutical supply chain, engaging in the production, distribution, and direct sale of medicinal products throughout the country.
Precio por acción
$2.64
Última sincronización: 2026-10-20
Capitalización bursátil
$3.01B
Cambio (1 día)
-4.30%
Cambio (1 año)
0.89%
País
CN
Comercio DaShenLin Pharmaceutical Group Co., Ltd. (603233)
Categoría
Healthcare
Ganancias de DaShenLin Pharmaceutical Group Co., Ltd. (603233)
Ganancias en Jun 2026 TTM: $296.94M
Secondo gli ultimi rapporti finanziari di DaShenLin Pharmaceutical Group Co., Ltd., gli utili attuali della società sono $296.94M. Nel 2023, la società ha registrato un utile di $229.96M, un aumento con respecto a agli utili del 2022, che erano di $205.12M. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de DaShenLin Pharmaceutical Group Co., Ltd. desde 2012 hasta 2026
Ganancias al final de cada año
| Año | Ganancias | Cambiar |
|---|---|---|
| 2026 (TTM) | $296.94M | 61.79% |
| 2024 | $183.54M | -20.19% |
| 2023 | $229.96M | 12.11% |
| 2022 | $205.12M | 24.89% |
| 2021 | $164.24M | -25.82% |
| 2020 | $221.41M | 67.67% |
| 2019 | $132.05M | 26.23% |
| 2018 | $104.61M | 7.25% |
| 2017 | $97.53M | 17.26% |
| 2016 | $83.17M | -2.54% |
| 2015 | $85.34M | 24.77% |
| 2014 | $68.40M | 29.00% |
| 2013 | $53.02M | 35.78% |
| 2012 | $39.05M | 0.00% |
Ganancias de empresas similares o competidoras
| Empresa | Ganancias | Diferencia de ganancias | País |
|---|---|---|---|
| $5.27B | 1,676.42% |
US
|
|
| $-3.09B | -1,139.60% |
US
|
|
| $-4.02B | -1,452.53% |
AU
|
|
| - | - |
CH
|
|
| $1.95B | 556.92% |
NL
|
